• Group of action: Agents affecting the nervous system

  • Active ingredient: Cinnarizine

  • Dosage form: Tablets

  • Pharmacotherapeutic group: Agents, used for vestibular disorders

  • ATC code: N07CA02

  • RX/OTC: RX

Disorders of cerebral circulation:

  • symptomatic treatment of cerebrovascular disorders including vertigo, ringing in the ears (tinnitus), headache vascular origin, irritability, memory loss and inability to concentrate;
  • migraine prophylaxis.

Peripheral circulatory disorders:

  • Symptomatic treatment of peripheral vascular disorders including Raynaud's disease, akrocyanosis, intermittent claudication, trophic disorders, trophic and varicose ulcers, paresthesia, nocturnal cramps in the limbs, cold limbs.

Balance disorders:

  • symptomatic treatment of labyrinth disorders including vertigo, tinnitus, nystagmus, nausea and vomiting.

Motion Sickness:

  • Prevention of motion sickness

Hypersensitivity to the active substance or to any of the excipients of the drug.

Tablets of white or almost white color.

5 years

Keep out of reach of children in the original packaging at a temperature not exceeding 25 ° C